Key findings:

• Eleven types of cancer are increasing in individuals aged 20 to 49 in England.
• Obesity is identified as a major driver behind these rising cancer rates.
• The cancers linked to obesity include thyroid, multiple myeloma, liver, kidney, gallbladder, colorectal, pancreatic, endometrial, oral, breast, and ovarian cancers.
• Bowel cancer rates in younger women linked to BMI rose from 0.9 to 1.6 per 100,000 people.
• Approximately 31,000 cancers were diagnosed in people aged 20 to 49 in England in 2023.

Research shows that for nine of the eleven cancers, incidence rates are increasing among both younger and older adults. Smoking rates among younger adults have fallen by about two percent annually over the last two decades. In contrast, obesity-related cancers are on the rise. Professor Montserrat García‑Closas stated that the trends are unlikely to be explained by changes in most known behavioral risk factors.

Professor Kristian Helin emphasized the need for stronger public health policies to tackle obesity across all ages. He noted that addressing this issue could slow the rise in cancer cases and prevent many cancers from developing. However, officials have not confirmed what specific interventions will be implemented.

Despite these increases, cancer remains a rare disease among young people. Professor Amy Berrington pointed out that while rates have been increasing, it still affects a small portion of this demographic. The exact causes behind this rise remain unclear and require further research.

The post 11 cancers young people appeared first on News Casino.

The noble false widow spider, first spotted in the UK in 1879, has seen its population explode since the early 2000s. This species is now considered the most venomous spider in the UK and is commonly found in urban habitats, making it the second most prevalent spider in such environments in Ireland and likely in the UK as well.

Experts attribute the surge in false widow spider populations to factors such as globalisation and possibly climate change. Dr. Michel Dugon noted, “We know that those species indeed can actually bite, that they do have a preference to live in and around houses rather than in natural habitats, at least in the UK and Ireland.” This adaptability allows them to thrive in human environments.

While bites from these spiders can lead to severe symptoms, including pain, tremors, and dizziness, they are not aggressive and typically only bite when provoked. However, some bites can carry harmful bacteria, leading to serious secondary infections.

Clive Hambler, a biologist, remarked, “The days when you could just treat spiders as benign in Britain are over.” This sentiment reflects the growing awareness of the potential dangers posed by these spiders.

In 2025, the increase in hospital admissions linked to spider bites has prompted discussions about public safety and awareness. Chris Keegan, a bite victim, shared his experience, stating, “Something so tiny and trivial if ignored could have led to my thumb or hand being removed, or sepsis could have set in.” His case underscores the importance of recognizing the risks associated with false widow spiders.

Details remain unconfirmed regarding the exact reasons for the population explosion of false widow spiders, as well as the specific role of climate change in their spread. Nonetheless, the public is urged to be cautious and informed about these increasingly common arachnids.

Reducing outdoor lighting can help minimize the number of insects attracted to homes, making them less appealing to spiders. Additionally, removing all spiders from homes can inadvertently allow false widows to settle in due to a lack of competition.

The post False Widow Spider UK: Rising Concerns Over Spider Bites appeared first on News Casino.

HPV vaccination typically occurs during adolescence, a time when routine pediatric visits are less common. This gap in healthcare access can hinder vaccination efforts, making it vital for public health initiatives to adapt their strategies. Organizations like PATH have collaborated with immunization program managers to assess the operational context and estimate the ongoing costs associated with HPV vaccine delivery. Their research has provided valuable insights into implementing a two-dose HPV vaccination schedule across six countries: Ethiopia, Guyana, Rwanda, Senegal, Sri Lanka, and Uganda.

In line with global health initiatives, the World Health Organization (WHO) has established the 90-70-90 targets for 2030, aiming to eliminate cervical cancer as a public health threat. One of these targets is to ensure that 90% of girls are vaccinated against HPV by the age of 15. Rwanda stands out as a success story, having achieved vaccination coverage close to 98%. This achievement underscores the potential for effective vaccination programs to drastically reduce the incidence of cervical cancer.

More than 90% of cervical cancer deaths occur in low- and middle-income countries, highlighting the urgent need for equitable access to vaccination and screening. The first World Cervical Cancer Elimination Day was observed in November 2025, marking a significant milestone in the global health agenda. Experts emphasize that “Cervical cancer should no longer be killing women,” pointing to the preventable nature of the disease and the importance of early detection and treatment.

Despite the progress made, challenges remain. The tragedy of cervical cancer is not just in its prevalence but also in the inequalities that underpin it. Women in lower-income regions often lack access to necessary healthcare services, including vaccinations and screenings. As a result, cervical cancer elimination must become a financing priority to ensure that all women, regardless of their socio-economic status, have the opportunity to protect themselves.

The WHO’s targets for 2030 also include ensuring that 90% of women are screened by age 35 and again by age 45, as well as treating 90% of women with cervical disease. Achieving these goals will require concerted efforts from governments, health organizations, and communities to prioritize cervical cancer prevention and treatment.

As the global community rallies to combat cervical cancer, the tools are available, and the window for action is open. However, the path forward is fraught with uncertainties regarding funding, healthcare infrastructure, and public awareness. Continued advocacy and investment in HPV vaccination programs are essential to realize the vision of a world where cervical cancer is no longer a public health threat.

The post Hpv vaccine: The Impact of on Cervical Cancer Prevention appeared first on News Casino.

The recall of British Bresaola from The Curing Barn has been initiated due to contamination with Listeria monocytogenes. This bacterium poses a potential health risk, particularly for vulnerable populations.

The affected product is packaged in 60g packs, with a use-by date of June 10, 2026. The recall was announced on April 5, 2026, following the detection of Listeria in the product.

The Food Standards Agency (FSA) has advised consumers not to consume the affected Bresaola and to return it to the place of purchase for a full refund. Customers do not need a receipt to process the return.

According to the FSA, symptoms associated with Listeria infection can resemble flu, including high temperature, muscle aches, chills, nausea, and diarrhea. In rare cases, it can lead to severe complications such as meningitis.

Vulnerable groups, including individuals over 65, pregnant women, infants under one month, and those with weakened immune systems, are particularly at risk from Listeria infections.

The batch codes affected by this recall are WLRC, J1Z2, 0WD0, and J85J. The Curing Barn’s British Bresaola was sold at Tesco for £4.50.

The FSA regularly issues Product Recall Information Notices to keep consumers informed about food safety issues. They emphasize the importance of staying updated on food safety alerts.

In response to the recall, The Curing Barn stated, “Listeria monocytogenes is a bacterium that is potentially harmful if consumed.” They are cooperating with the FSA to ensure consumer safety.

As the situation develops, consumers are encouraged to remain vigilant and check for updates regarding food safety alerts and recalls.

Details remain unconfirmed regarding the extent of distribution and any potential health impacts from the contaminated product.

The post Curing Barn British Bresaola Recall appeared first on News Casino.

A national recall affecting oils containing CBD and hemp extracts for pets, including chien, was issued on April 1, 2026. This decision has significant implications for pet owners across France, as the recall targets all lots of CBD and hemp-extract oils marketed for cats and dogs under the brands CBDSOL and Mama Kana.

The recall covers products sold between March 18, 2022, and March 19, 2026, prompting consumers to stop using these products immediately. They are instructed to return them to the point of sale or to destroy them. A refund procedure for the recalled products is available until September 1, 2026.

The Ministry of the Economy in France stated that CBD and hemp extracts are unauthorized additives for animal nutrition, emphasizing the need for regulation in this area. “They are regulated and require authorization for their marketing and use,” the Ministry noted.

This recall is part of a broader scrutiny of pet products containing CBD, which have gained popularity in recent years. However, the safety and efficacy of these products for animals remain under question.

In light of this recall, pet owners are urged to be vigilant and informed about the products they use for their pets. The potential health risks associated with unauthorized additives can have serious consequences for animal welfare.

Details remain unconfirmed regarding the specific health impacts of the recalled products. However, the swift action taken by authorities indicates a serious concern over the safety of these items.

As the situation develops, further information is expected from health and regulatory agencies regarding the implications of this recall and any additional measures that may be necessary to ensure pet safety.

In the meantime, consumers are encouraged to seek alternative, approved products for their pets and to stay updated on any new guidelines issued by health authorities.

This recall serves as a reminder of the importance of regulatory oversight in the pet product industry, particularly as new trends, such as the use of CBD, continue to emerge.

As the public awaits further developments, the focus remains on ensuring the safety and well-being of pets across the nation.

The post Chien Recall: CBD and Hemp Extracts for Pets in France appeared first on News Casino.

Before the emergence of the Cicada variant, the COVID-19 landscape in the UK was characterized by a gradual decline in cases and hospitalizations, largely attributed to the effectiveness of existing vaccines against earlier strains. The public health focus was on managing the remaining cases and ensuring vaccination coverage, with expectations that the pandemic was nearing an end. However, the detection of the Cicada variant has shifted this narrative significantly.

The decisive moment came when the Cicada variant, designated BA.3.2, was first identified in South Africa in November 2024. By March 2026, it had been reported in 24 countries, including the UK. The variant carries between 70 to 75 genetic changes in its spike protein, which has raised alarms among health officials. The variant’s rapid spread, making up approximately 30% of COVID-19 sequences reported in Denmark, Germany, and the Netherlands from late 2025 to early 2026, indicates its potential for widespread transmission.

The direct effects of the Cicada variant on public health are still unfolding. Symptoms associated with this variant include a particularly painful sore throat, fever, cough, fatigue, and nasal congestion. While there is no evidence that the Cicada variant causes more severe disease than previous variants, its ability to evade antibodies due to significant mutations poses a challenge for current vaccines. Experts have noted that the existing COVID-19 vaccine may be less effective against this variant.

Experts like Kyle B. Enfield have expressed concerns about the variant’s implications, stating, “Because it’s significantly different, the current COVID-19 vaccine may not be as effective.” Ian Budd highlighted the number of mutations, particularly on the virus’s spike protein, as a critical factor in its transmissibility. The CDC has warned that the Cicada strain “could be associated with seasonal increases in COVID-19 activity,” emphasizing the need for continued vigilance.

As of now, the UK has confirmed cases of the Cicada variant, and public health officials are monitoring the situation closely. The variant’s emergence comes at a time when the healthcare system is still recovering from the previous respiratory virus season, which saw an estimated 390,000 to 550,000 hospitalizations and 45,000 to 64,000 deaths. This context adds urgency to the response to the Cicada variant.

Despite the concerning mutations, experts have reassured the public that there is currently no sign that BA.3.2 is more dangerous than variants circulating in the winter of 2025-26. “There’s no sign so far that BA.3.2, nicknamed Cicada, is any more dangerous or causes more severe disease than the variants that were circulating in the winter of 2025-26,” stated Enfield. However, the uncertainty surrounding the long-term effectiveness of current vaccines against this variant remains a significant concern.

The Cicada variant is named after the insect that lies dormant for years before emerging, reflecting its ability to remain undetected before spreading. This metaphor underscores the challenges faced by public health officials in tracking and managing emerging variants. Details remain unconfirmed regarding the exact impact of the Cicada variant on public health due to limited genomic detection and surveillance capacities in many countries.

The post COVID 19 Cicada Variant UK: Understanding the New Developments appeared first on News Casino.

The BA.3.2 variant, nicknamed Cicada, is spreading quickly across the United States. As of February 2026, it has been detected in 23 countries and 29 U.S. states, raising alarms among health officials.

First identified in November 2024 in Africa, the BA.3.2 variant carries 70 to 75 genetic changes in its spike protein, which may affect how the virus interacts with the immune system. Experts are concerned that these mutations could allow the variant to evade immunity from previous infections or current vaccines. “Due to the high number of mutations, experts worry the variant may more easily bypass immunity from previous infections or current vaccines,” a health official stated.

Despite these concerns, there is currently no evidence that BA.3.2 causes more severe disease than previous variants. Emily Ronay Johnston, a virologist, noted, “There’s no sign so far that BA.3.2, nicknamed Cicada, is any more dangerous or causes more severe disease than the variants that were circulating in the winter of 2025-26.” This sentiment is echoed by other experts who emphasize that the majority of people infected with this variant report relatively mild illness, particularly among those who are vaccinated.

COVID-19 continues to pose a public health challenge, with the virus causing 300-500 deaths per week in the U.S. The first U.S. case of BA.3.2 was detected in a traveler in June 2025, indicating that the variant has been present for several months. While the variant may infect people more widely due to immune evasion, it is not considered more dangerous than its predecessors.

The historical context of the BA.3.2 variant is important, as it is descended from the Omicron variant, which emerged in late 2021. This lineage has been characterized by its rapid spread and mutations, leading to ongoing adjustments in public health responses and vaccine strategies.

As health officials continue to monitor the situation, the long-term impact of the BA.3.2 variant on public health remains unclear. The effectiveness of current vaccines against this variant is also not fully confirmed. Details remain unconfirmed.

In summary, while the Cicada variant is spreading rapidly and presents challenges due to its mutations, experts advise that there is no immediate cause for panic. The situation is being closely monitored as more data becomes available, and public health measures continue to adapt to the evolving landscape of COVID-19 variants.

The post Covid 19 cicada variant: COVID-19 Cicada Variant Spreads Rapidly Across the U.S. appeared first on News Casino.

Until recently, expectations surrounding services for myalgic encephalomyelitis (ME) in Wales were relatively optimistic. The Welsh government had committed to providing funding for health boards to establish necessary services for those affected by ME. This move was seen as a significant step towards improving care and support for patients suffering from this debilitating condition.

However, a decisive moment has emerged as disparities in service provision have begun to surface, leading to what has been described as a developing postcode lottery. Without a comprehensive all-Wales plan, access to ME services is becoming inconsistent, leaving many patients in certain regions without adequate support.

The implications of this shift are profound for those affected by ME. Patients in areas with robust services may receive timely and effective care, while others may find themselves struggling to access even basic support. This inconsistency can exacerbate the challenges faced by individuals already dealing with the complexities of ME.

Experts have noted that the lack of a unified approach to ME services in Wales could undermine the progress made by the Welsh government. As one commentator pointed out, “There’s a bit of a postcode lottery developing,” highlighting the urgent need for a cohesive strategy to ensure equitable access to care.

In a different context, political figures such as Keir Starmer have also been making headlines, particularly regarding his stance on international conflicts. Starmer has firmly stated, “I will not be wavering on this,” referring to his position on the Iran war, which he believes is not in the best interests of the UK.

Starmer’s comments reflect a broader trend in political discourse, where leaders are increasingly scrutinized for their positions on international issues. He emphasized, “This is not our war, and we are not getting dragged into this war,” indicating a commitment to prioritizing national interests over external pressures.

While the political landscape continues to evolve, the situation for ME patients in Wales remains critical. The Welsh government’s funding initiative is a positive development, but without a coordinated plan, the benefits may not reach all those in need.

As the situation unfolds, the voices of affected individuals and experts will be crucial in shaping the future of ME services in Wales. The call for a comprehensive approach to healthcare for ME patients is more urgent than ever, as disparities in service provision could lead to long-term consequences for those affected.

Details remain unconfirmed regarding the next steps the Welsh government will take to address these disparities, but the need for action is clear.

The post Me: Updates on Services in Wales appeared first on News Casino.

A bacterial meningitis outbreak in Kent has resulted in two fatalities and a total of 29 confirmed or suspected cases. The outbreak, primarily involving meningitis B, has raised concerns among local health officials and the community.

As of the latest reports, the number of confirmed meningitis cases has decreased from 23 to 20, while suspected cases have fallen from 11 to 9. This brings the total number of cases down from 34 to 29. Dr. Ahmed, a health official, confirmed that two individuals have died, and a nine-month-old child is currently in intensive care.

Four schools in Kent have reported confirmed or suspected cases of meningitis. Among the affected, Juliette Kenny, a Year 13 student at Queen Elizabeth’s Grammar School, has been identified as one of the fatalities. Additionally, a pupil at Norton Knatchbull School has been confirmed with meningitis, while another Year 13 pupil at Simon Langton Grammar School for Boys is hospitalized with the illness.

Health authorities have responded by administering over 9,078 meningitis B vaccines in Kent and distributing 12,595 courses of antibiotics to individuals at risk. Dr. Ahmed emphasized the importance of rapid treatment, stating, “Meningitis can be very serious if not treated quickly and can cause sepsis.”

The outbreak can be traced to a single location, and health officials are closely monitoring the situation. Dr. Ahmed noted that meningitis spreads through close contact and sharing items that may carry bodily fluids, such as utensils and vapes.

This type of outbreak is not entirely unexpected, as the UK typically sees three to 400 cases of meningitis B annually, often occurring in small clusters. Dr. Ahmed reassured the public, stating, “While it’s very scary that it can just start symptoms within two days and then kill someone within another couple of days, it just doesn’t have the characteristics that will allow for a national outbreak and a lockdown.”

Authorities continue to encourage vaccination and awareness of symptoms as they work to contain the outbreak. The community is urged to remain vigilant and report any suspected cases to health officials.

The post Bacterial meningitis outbreak kent: Bacterial Meningitis Outbreak in Kent appeared first on News Casino.

Before the recent developments, residents of Bentham, North Yorkshire, were largely unaware of the potential health risks posed by PFAS, commonly known as forever chemicals due to their persistence in the environment. However, a series of blood tests conducted on local residents have revealed alarming levels of these toxic substances.

As of March 20, 2026, it was reported that Bentham has the highest recorded level of PFAS contamination in the UK. Testing involved 39 residents and former workers, with results showing that the highest PFAS level recorded was an astonishing 405 ng/ml. This figure starkly contrasts with the US risk level of 2 ng/ml, which indicates potential health risks.

Among those tested, 23% were found to have PFAS levels placing them in the highest risk category. Notably, nine individuals had levels exceeding 20 ng/ml, a threshold associated with increased risk of adverse health effects. This alarming data has raised significant concerns among the local population.

Dr. David Megson, who analyzed the data, expressed shock at the findings, stating, “I was absolutely shocked when we started to run this data.” His sentiments were echoed by Dr. Shubhi Sharma, who highlighted the serious health implications, noting, “The PFAS levels in people’s blood in Bentham are alarming, especially given that these chemicals have been linked to a variety of adverse health outcomes including certain cancers.”

Residents like Stephen Illston have begun to question the safety of their environment. Illston remarked, “It’s good to hear it’s not me, maybe it’s the PFAS that’s caused it.” This reflects a growing anxiety among the community regarding the potential health problems linked to PFAS contamination.

Furthermore, the Environment Agency has indicated that aerial dispersal from firefighting foam testing conducted by Angus Fire, which produced PFAS-containing foam from 1976 to 2024, could have exposed residents to these harmful chemicals. Currently, there are no UK guidelines for safe PFAS levels in blood, leaving residents in a state of uncertainty.

In light of these findings, local residents are increasingly concerned about their health and the safety of their families. Rachel Harrison, a local parent, stated, “If I have the opportunity to move my children away from something that could cause them harm, you’re going to do that.” This sentiment underscores the urgency for action and clarity regarding PFAS contamination in Bentham.

As the situation develops, the community awaits further guidance and support from health authorities to address the implications of these findings. Details remain unconfirmed regarding the long-term health impacts of such high PFAS levels, but the immediate concerns are clear.

The post Bentham: PFAS Contamination in : A Growing Concern appeared first on News Casino.